Israel - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Israel Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry increased 0.6% year on year. In 2019, the country was number 21 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry with $287,878,980.84 Million PPP. Israel is overtaken by Netherlands, which was number 20 with $289,193,594.01 Million PPP and is followed by Poland at $268,990,772.83 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, +3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania recorded the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 287,878,980.84 |
| 2018 | 290,427,144.48 |
| 2017 | 271,549,367.22 |
| 2016 | 341,745,424.49 |
| 2015 | 349,550,620.30 |
How does Israel rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 20 |
#20
Netherlands
|
289,193,594.01 | 2019 | -3.4 % | -1.8 % | View data | |
| 21 |
#21
Israel
|
287,878,980.84 | 2019 | -0.9 % | +0.6 % | View data | |
| 22 |
#22
Poland
|
268,990,772.83 | 2019 | +5.0 % | +12.3 % | View data | |